HCA Healthcare, Inc. $HCA is Tuttle Capital Management LLC’s 2nd Largest Position

Tuttle Capital Management LLC boosted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 14.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,046 shares of the company’s stock after buying an additional 264 shares during the quarter. HCA Healthcare makes up 3.2% of Tuttle Capital Management LLC’s holdings, making the stock its 2nd biggest position. Tuttle Capital Management LLC’s holdings in HCA Healthcare were worth $784,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Chung Wu Investment Group LLC acquired a new stake in HCA Healthcare in the second quarter valued at approximately $27,000. Ameriflex Group Inc. purchased a new stake in HCA Healthcare in the 2nd quarter worth $27,000. Cheviot Value Management LLC acquired a new stake in shares of HCA Healthcare in the first quarter valued at about $26,000. Saudi Central Bank acquired a new position in shares of HCA Healthcare during the 1st quarter worth about $26,000. Finally, WPG Advisers LLC acquired a new stake in HCA Healthcare in the 1st quarter worth about $27,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the topic of a number of research analyst reports. KeyCorp lifted their price target on HCA Healthcare from $370.00 to $465.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. Robert W. Baird upped their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research note on Thursday, August 14th. JPMorgan Chase & Co. boosted their target price on HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a report on Monday, August 4th. Finally, UBS Group lifted their price objective on HCA Healthcare from $438.00 to $495.00 and gave the stock a “buy” rating in a research report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $431.07.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA opened at $418.34 on Wednesday. The stock has a market cap of $97.89 billion, a PE ratio of 17.58, a P/E/G ratio of 1.29 and a beta of 1.40. The firm has a 50-day simple moving average of $407.16 and a two-hundred day simple moving average of $376.85. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $439.01.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter last year, the firm earned $5.50 EPS. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.